Publications from MSIF and other stakeholders in support of work on access to MS healthcare.
MSIF's work relating to off-label DMTs for MS
Advocating for the addition of MS treatments to the WHO Essential Medicines List
Addressing barriers to accessing treatment at a global, regional and national level
Collaborating with the Medicines Patent Pool as MSIF continues work on improving access to MS treatments
Studies provide insight into the links between MS prevalence, severity, latitude and healthcare spending
MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders, including MS
This was written by Joanna Laurson-Doube for OneNeurology on World Brain Day.
MSIF’s international working group on access comes together to advance the global agenda on access to treatments
The Convention was adopted by the UN General Assembly in 2006
Al-Hayat Association in Iraq has successfully lobbied the Ministry of Health to provide better access to the MS treatment, rituximab. The campaign is part of the organisation’s aim to secure a range of treatments for people with MS in Iraq. Learn more about their campaign success.
People with MS, caregivers and MS organisations from across the world come together
In August Sarah Dobson, MSIF’s Senior Communications and Campaigns Officer, met with local MS organisations in Taiwan and South Korea.
The Corporación Esclerosis Múltiple Chile shares the secrets of their success in improving access to treatment.
Global MS employment report shows many people with MS are leaving employment earlier than necessary
Examples of accessible resorts and services shared by our members
The theme for World MS Day 2014 was access
People with MS test out new accessible facilities